Diabetic Nephropathy (Phase 2)

You will be directed to the website of the host of this Clinical Trial.

Details:

This 62 week study if for people with Type I or Type II Diabetes, who have impaired kidney function, including protein in the urine. It requires 18 visits to our Auburn Avenue office. The study medication is an injectable (every 2 weeks) monoclonal antibody.

Contact Info:

Name: Donna Percy
Phone: 513-671-8080

Eligibility:

  • 21 to 80 years old
  • Protein in the urine
  • Hemoglobin A1C 7.5 to 10.5%
  • Currently on an ACE-inhibitor or "ARB"
  • NOT recieving kidney dialysis

Compensation:

$50 to $75 per visit; upt to $1050

Location:

Sterling Research Group

N/A